|
- ONAPGO™ - Official Patient Website
ONAPGO, continuous apomorphine infusion, is for the treatment of motor fluctuations (OFF episodes) in adults with advanced Parkinson’s disease (PD) In a clinical trial, ONAPGO provided more consistent control of OFF time Meet real people with Parkinson’s who go ON with ONAPGO
- ONAPGO™ - A Wearable Device for Parkinson’s Disease
Discover ONAPGO™ (apomorphine HCl) injection, for subcutaneous infusion ONAPGO is the first and only minimally invasive treatment for Parkinson’s disease
- Onapgo: Uses, Dosage, Side Effects, Warnings - Drugs. com
What is Onapgo? Onapgo (apomorphine hydrochloride) is a wearable Infusion device used to help relieve motor fluctuations in adults with advanced Parkinson's disease
- ONAPGO: A Newly-Approved Medication for OFF Periods in Parkinson’s
The first subcutaneous (under the skin) apomorphine infusion, now called ONAPGO TM, was approved by the Food and Drug Administration (FDA) on February 4, 2025 Apomorphine is a dopamine agonist whose effects have a rapid onset
- Onapgo (apomorphine): Uses, Side Effects, Interactions . . . - WebMD
Overview: Onapgo is used to treat certain symptoms of Parkinson’s disease It is an injectable medicine given under your skin as a continuous infusion using a pump Onapgo is thought to work like
- Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride . . .
Supernus will make ONAPGO available in the second quarter of 2025 with a support team of experts, including a robust nurse education program, and access support at launch
- Onapgo (apomorphine hydrochloride) for Parkinson’s disease
Onapgo, an apomorphine infusion device formerly called SPN-830, is approved in the U S for reducing Parkinson's motor symptom fluctuations
- Full Prescribing Information - onapgo. com
ONAPGO is indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease ONAPGO is indicated for subcutaneous use by infusion only [see Warnings Precautions (5 1)]
|
|
|